Themis Medicare Limited Total Liabilities
Themis Medicare Limited total liabilities. Based on the latest financial reports, Themis Medicare Limited (THEMISMED) has total liabilities worth Rs-3.99 Billion INR (≈ $-43.11 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Themis Medicare Limited liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Themis Medicare Limited (2006–2026)
Total liabilities of Themis Medicare Limited from 2006 to 2026. This chart illustrates how Themis Medicare Limited's total liabilities have evolved over time, based on quarterly financial data. Explore Themis Medicare Limited long-term investment allocation to see how much of total assets are deployed in long-term investments.
Themis Medicare Limited Competitors by Total Liabilities
The table below lists competitors of Themis Medicare Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Black Diamond Therapeutics Inc
NASDAQ:BDTX
|
USA | $28.94 Million |
|
Economic Investment Trust Ltd
TO:EVT
|
Canada | CA$158.27 Million |
|
Taseco Air Services JSC
VN:AST
|
Vietnam | ₫298.09 Billion |
|
Ilsung Pharm
KO:003120
|
Korea | ₩14.27 Billion |
|
Dyaco International Inc
TW:1598
|
Taiwan | NT$5.20 Billion |
|
Carbios
PA:ALCRB
|
France | €65.53 Million |
|
Rockridge Resources Ltd
V:ROCK
|
Canada | CA$11.46 Million |
Liability Composition Analysis (2006–2026)
This chart breaks down Themis Medicare Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see THEMISMED current and non-current assets.
Liquidity & Leverage Metrics
Themis Medicare Limited Total Liabilities Ratios Explained
Themis Medicare Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | N/A | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Themis Medicare Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Themis Medicare Limited (2006–2026)
The table below shows the annual total liabilities of Themis Medicare Limited from 2006 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs1.99 Billion ≈ $21.56 Million |
+7.49% |
| 2025-03-31 | Rs1.85 Billion ≈ $20.05 Million |
-1.76% |
| 2024-03-31 | Rs1.89 Billion ≈ $20.41 Million |
+8.16% |
| 2023-03-31 | Rs1.75 Billion ≈ $18.87 Million |
+24.39% |
| 2022-03-31 | Rs1.40 Billion ≈ $15.17 Million |
-8.09% |
| 2021-03-31 | Rs1.53 Billion ≈ $16.51 Million |
-8.54% |
| 2020-03-31 | Rs1.67 Billion ≈ $18.05 Million |
+6.96% |
| 2019-03-31 | Rs1.56 Billion ≈ $16.87 Million |
+14.38% |
| 2018-03-31 | Rs1.36 Billion ≈ $14.75 Million |
-27.94% |
| 2017-03-31 | Rs1.89 Billion ≈ $20.47 Million |
-4.03% |
| 2016-03-31 | Rs1.97 Billion ≈ $21.33 Million |
-10.50% |
| 2015-03-31 | Rs2.20 Billion ≈ $23.84 Million |
-3.64% |
| 2014-03-31 | Rs2.29 Billion ≈ $24.74 Million |
+4.12% |
| 2013-03-31 | Rs2.20 Billion ≈ $23.76 Million |
-0.83% |
| 2012-03-31 | Rs2.22 Billion ≈ $23.96 Million |
+9.14% |
| 2011-03-31 | Rs2.03 Billion ≈ $21.95 Million |
+5.31% |
| 2010-03-31 | Rs1.93 Billion ≈ $20.84 Million |
-4.83% |
| 2009-03-31 | Rs2.03 Billion ≈ $21.90 Million |
+7.64% |
| 2008-03-31 | Rs1.88 Billion ≈ $20.35 Million |
+15.97% |
| 2007-03-31 | Rs1.62 Billion ≈ $17.54 Million |
+67.46% |
| 2006-03-31 | Rs968.77 Million ≈ $10.48 Million |
-- |
About Themis Medicare Limited
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It provides active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic, anti-diabetic, a… Read more